Australian court rejects Boehringer opposition bid against MSD unit’s anti-parasitic drug patent

24-05-2022

Sarah Speight

Australian court rejects Boehringer opposition bid against MSD unit’s anti-parasitic drug patent

anastas_styles / Shutterstock.com

The Federal Court of Australia has refused an appeal request in a decade-long case brought by Boehringer Ingelheim Animal Health against MSD subsidiary, Intervet International.


Boehringer, MSD, Intervet, patents, anti-parasitics, Federal Court of Australia

LSIPR